☆ 4.6 Editorial Material

Bioenergetic remodeling in the pathophysiology and treatment of nonalcoholic fatty liver disease

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Related references

Note: Only part of the references are listed.

Review Medicine, General & Internal

A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease

Qing Gu et al.

Summary: This study compared the efficacy and accuracy of MRI and TE for assessing hepatic steatosis in NAFLD patients. The results showed that both MRI-PDFF and TE-CAP are highly accurate noninvasive methods for quantifying and staging hepatic steatosis in NAFLD. MRI-PDFF is significantly more accurate than TE-CAP for evaluating dichotomized grades of steatosis.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD

Stefania Di Mauro et al.

Summary: NAFLD, a common liver disease in industrialized countries, can progress to serious conditions. Liver biopsy is the gold standard for diagnosis, but non-invasive biomarkers are needed to identify high-risk patients.Various omics approaches are being explored to uncover novel biomarkers for accurate NAFL/NASH diagnosis and fibrosis staging.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Pharmacology & Pharmacy

Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions

Patrick Campbell et al.

Summary: NAFLD, a highly prevalent chronic liver disease driven by metabolic syndrome, currently relies on risk factor control and lifestyle changes for weight loss. Due to difficulty in sustained weight loss for many patients, there is a critical need for pharmacotherapy to treat NAFLD, especially NASH, to prevent cirrhosis.

CLINICAL THERAPEUTICS (2021)

Add to Collection

Article Endocrinology & Metabolism

Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease

Chris E. Shannon et al.

Summary: Insulin resistance and altered hepatic mitochondrial function are key features of type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD). This study found that insulin sensitization with pioglitazone can mitigate mitochondrial dysfunction in the liver, which is independent of changes in hepatic lipid accumulation. The research highlights potential therapeutic targets for T2D and NAFLD, emphasizing the benefits of insulin sensitization in managing obesity-related diseases.

MOLECULAR METABOLISM (2021)

Add to Collection

Article Gastroenterology & Hepatology

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Stephen A. Harrison et al.

Summary: In a cohort of asymptomatic middle-aged Americans, the prevalence of NAFLD was 38%, NASH was 14%, and significant liver fibrosis was present in 6% of the participants.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach

Giovanni Targher et al.

Summary: NAFLD is not only a global public health issue but also proven to be a systemic disease, closely related to various extrahepatic complications. Addressing NAFLD requires establishing a multidisciplinary working group and framework to achieve comprehensive, person-centered care and management.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

Leen J. M. Heyens et al.

Summary: NAFLD progression from isolated steatosis to fibrosis involves liver inflammation leading to fibrosis, cirrhosis, and even hepatocellular carcinoma. Fibrosis is a crucial predictor of prognosis in NAFLD patients, but accurate detection and treatment methods are lacking.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Review Endocrinology & Metabolism

Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity

Herbert Tilg et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a global pandemic that particularly affects patients with obesity and type 2 diabetes. The complex interplay between metabolic dysregulation, altered gut microbiome and dysregulated innate and adaptive immunity contributes to the pathology and progression of NAFLD.

NATURE METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease

Nikolaos Perakakis et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Add to Collection

Article Endocrinology & Metabolism

Fructose stimulated de novo lipogenesis is promoted by inflammation

Jelena Todoric et al.

NATURE METABOLISM (2020)

Add to Collection

Review Gastroenterology & Hepatology

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

Laurent Castera et al.

GASTROENTEROLOGY (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Environmental Risk Factors for Liver Cancer and Nonalcoholic Fatty Liver Disease

Trang VoPham

CURRENT EPIDEMIOLOGY REPORTS (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Understanding Environmental Contaminants' Direct Effects on Non-alcoholic Fatty Liver Disease Progression

Laura E. Armstrong et al.

CURRENT ENVIRONMENTAL HEALTH REPORTS (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Mechanisms of Environmental Contributions to Fatty Liver Disease

Banrida Wahlang et al.

CURRENT ENVIRONMENTAL HEALTH REPORTS (2019)

Add to Collection

Review Endocrinology & Metabolism

Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease

Lindsey S. Trevino et al.

ENDOCRINOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Treatment of NAFLD with diet, physical activity and exercise

Manuel Romero-Gómez et al.

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes

Zobair M. Younossi et al.

HEPATOLOGY (2016)

Add to Collection

Article Environmental Sciences

Secondhand tobacco exposure is associated with nonalcoholic fatty liver disease in children

Connie Lin et al.

ENVIRONMENTAL RESEARCH (2014)

Add to Collection

Review Endocrinology & Metabolism

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

Hannele Yki-Jarvinen

LANCET DIABETES & ENDOCRINOLOGY (2014)

Add to Collection

Review Medicine, General & Internal

Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis

Ines O. Goncalves et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)

Add to Collection

Article Gastroenterology & Hepatology

Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

Zobair M. Younossi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Fatty Liver Is Associated with Insulin Resistance, Risk of Coronary Heart Disease, and Early Atherosclerosis in a Large European Population

Amalia Gastaldelli et al.

HEPATOLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.